Literature DB >> 15108062

Consistency of low bone density across bone sites in SAMP6 laboratory mice.

Soichiro Kasai1, Motoyuki Shimizu, Takuro Matsumura, Shuzo Okudaira, Mutsumi Matsushita, Tadao Tsuboyama, Takashi Nakamura, Masanori Hosokawa.   

Abstract

The development of bone densitometry has made it clear that there are discrepancies in bone density at various measurement sites in a given individual. This study examined the consistency of bone density measurements across various sites in a strain of laboratory mouse (senescence-accelerated mouse; SAM). A systemic evaluation of the bone density was performed by dual-energy X-ray absorptiometry (DXA) on SAMP6 (P6) mice, a strain with low peak bone density, as measured by microphotodensitometry of the femoral bones, whereas the SAMP2 (P2) and SAMR1 (R1) strains have high peak bone density. We modified Jilka's method to more comprehensively measure the whole body and additional regions of interest (ROIs; head, right foreleg, left foreleg, right hindleg, left hindleg, spine, and tail). The age-related changes in the total (whole-body) BMD showed a common pattern among the strains studied, and the peak value was seen at 4 months old. P6 showed the lowest peak BMD. A detailed comparison of the bone density between P6 and P2 at the age of 4 months revealed significantly lower regional BMD values for P6 in all seven ROIs. The strain difference in BMD could not be attributed to a difference in size. In conclusion, P6 mice showed low bone density not only in their femurs but also in the subregions and over their entire body. This strain can be potentially useful in the investigation of the genetic basis of senile osteoporosis.

Entities:  

Mesh:

Year:  2004        PMID: 15108062     DOI: 10.1007/s00774-003-0471-1

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  8 in total

1.  Quantitative trait locus on chromosome X affects bone loss after maturation in mice.

Authors:  Shuzo Okudaira; Motoyuki Shimizu; Bungo Otsuki; Rika Nakanishi; Akira Ohta; Keiichi Higuchi; Masanori Hosokawa; Tadao Tsuboyama; Takashi Nakamura
Journal:  J Bone Miner Metab       Date:  2010-03-31       Impact factor: 2.626

2.  Dysregulated in vitro hematopoiesis, radiosensitivity, proliferation, and osteoblastogenesis with marrow from SAMP6 mice.

Authors:  Regina P O'Sullivan; Joel S Greenberger; Julie Goff; Shaonan Cao; Kiera A Kingston; Shuanhu Zhou; Tracy Dixon; Frank D Houghton; Michael W Epperly; Hong Wang; Julie Glowacki
Journal:  Exp Hematol       Date:  2012-02-10       Impact factor: 3.084

3.  Adiposity-related biochemical phenotype in senescence-accelerated mouse prone 6 (SAMP6).

Authors:  Kimie Niimi; Eiki Takahashi; Chitoshi Itakura
Journal:  Comp Med       Date:  2009-10       Impact factor: 0.982

4.  Effect of intermittent treatment with human Parathyroid Hormone 1-34 in SAMP6 senescence-accelerated mice.

Authors:  Y Washimi; H Chen; A Ito; R Takao; T Uzawa; Y Yamamoto; H Yamada; S Shoumura
Journal:  J Endocrinol Invest       Date:  2009-11-12       Impact factor: 4.256

5.  Bu-Gu-Sheng-Sui decoction promotes osteogenesis via activating the ERK/Smad signaling pathways.

Authors:  Ning Liu; Baoyu Qi; Yili Zhang; Shengjie Fang; Chuanrui Sun; Qiuyue Li; Xu Wei
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

Review 6.  Characterization of senescence-accelerated mouse prone 6 (SAMP6) as an animal model for brain research.

Authors:  Kimie Niimi; Eiki Takahashi
Journal:  Exp Anim       Date:  2014

7.  Bone marrow stromal cells from low-turnover osteoporotic mouse model are less sensitive to the osteogenic effects of fluvastatin.

Authors:  Yukari Oda; Hodaka Sasaki; Tadashi Miura; Takuya Takanashi; Yoshitaka Furuya; Masao Yoshinari; Yasutomo Yajima
Journal:  PLoS One       Date:  2018-08-24       Impact factor: 3.240

8.  Flavonoid compound icariin enhances BMP-2 induced differentiation and signalling by targeting to connective tissue growth factor (CTGF) in SAMP6 osteoblasts.

Authors:  Bing Xu; Xueqiang Wang; Chengliang Wu; Lihe Zhu; Ou Chen; Xiaofeng Wang
Journal:  PLoS One       Date:  2018-07-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.